Home
Advertisement & Sponsorship Options
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Home
Tags
Pembrolizumab
Tag: pembrolizumab
Cabozantinib + Pembrolizumab Shows ORR of 54% in Treatment of Recurrent or...
Danielle Garcia
-
June 4, 2022
Combination Trials with Immune Checkpoint Inhibitors may not Result in Synergistic...
Editorial Team
-
February 28, 2022
Pembrolizumab Shows Significantly Prolonged Event-free Survival in High-Risk Early-Stage TNBC
Editorial Team
-
February 9, 2022
The Path Toward Curative Treatments in Cervical Cancer
Jennifer Buell, Ph.D.
-
October 18, 2021
KEYNOTE-122: Pembrolizumab vs Chemotherapy in Platinum-Pretreated Nasopharyngeal Carcinoma
Editorial Team
-
September 20, 2021
Immunotherapy After Surgery Extends Disease-Free Survival for Select Patients With Kidney...
Editorial Team
-
June 7, 2021
Comprehensive Genomic and Transcriptomic Profiling Predicts Pan-Tumor Benefit of Pembrolizumab
Editorial Team
-
June 5, 2021
SNS-301 + Pembrolizumab well Tolerated as Treatment of Squamous Cell Carcinoma...
Editorial Team
-
May 27, 2021
Tebentafusp Significantly Improves Overall Survival in Patients With Metastatic Uveal Melanoma
Peter Hofland, Ph.D
-
April 11, 2021
Combination of SLC-391 + Pembrolizumab Enters Clinical Trial Advanced NSCLC
Peter Hofland, Ph.D
-
March 31, 2021
1
2
3
4
Page 1 of 4
LATEST NEWS
Study: Blocking Immune Suppressor Cells in Mice with Glioblastoma Improves Survival
Danielle Garcia
-
January 27, 2023
Stephen Spellman: Mismatched Unrelated Donors – Key to Erasing the Gap in Donor Availability...
Editorial Team
-
January 18, 2023
New Technologies in Post-surgical Wound Dressings
Brad Greer, JD
-
January 16, 2023
The Patient Journey Tech Stack: 10 Predictions for 2023
Yishai Knobel
-
January 16, 2023
Study Confirms: ‘Extreme Lack of Consistency’ Hampers the Potential of Nanosized Medicines
Danielle Garcia
-
January 12, 2023
X